USFDA classifies Cipla's Goa facility as OAI

USFDA classifies Cipla's Goa facility as OAI
Cipla Ltd informed the exchanges Wednesday post market hours that United States Food and Drug Administration (USFDA) has classified the inspection conducted at its Goa manufacturing facility from 16-27 September 2019 as Official Action Indicated (OAI).

The Company does not believe that this will have any material impact on the US business at this stage. The Company has a strong track record of maintaining the highest standard of compliance and will work closely with the agency to comprehensively address the observations received.

Stock view:
Cipla Ltd ended at Rs470.30 down by Rs2.95 or 0.62% from its previous closing of Rs473.25 on the BSE.




About Gosip4U

Gosip4U is the digital wing of india - India's leading media and communications group with its interests spanning across country.

0 comments:

Post a Comment

Please add comment